- Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC)
Hassaan Umar et al, 2024, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis CrossRef - Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma
Guiyan Xu et al, 2016, Tumor Biology CrossRef - Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression
Jing Dai et al, 2016, Oncotarget CrossRef - MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth
Jin-Feng Zhu et al, 2018, Cancer Cell International CrossRef - miRNAs as Modulators of EGFR Therapy in Colorectal Cancer
Diane M. Pereira et al, 2018, Targeted Therapy of Colorectal Cancer Subtypes CrossRef - Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy
Shanshan Wei et al, 2022, Cell Communication and Signaling CrossRef - miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets
Emiliya Nikolova et al, 2024, Non-coding RNA Research CrossRef - Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
Jinjin Chu et al, 2022, Frontiers in Oncology CrossRef - miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay — A review
Mahmoud A. Elrebehy et al, 2022, International Journal of Biological Macromolecules CrossRef - miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer
Daojiang Li et al, 2017, Oncotarget CrossRef - Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis
Charles M. Bowen et al, 2021, Cancer Prevention Research CrossRef - Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies
Madhav Madurantakam Royam et al, 2019, Molecular Diagnosis & Therapy CrossRef - Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer
Jiao Yang et al, 2016, Tumor Biology CrossRef - MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy
Matthew Goblirsch et al, 2017, Pharmacogenomics CrossRef - miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
Chen Lin et al, 2018, International Journal of Molecular Medicine CrossRef - Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics
Svetlana Miroshnichenko et al, 2019, Frontiers in Pharmacology CrossRef - Micro RNA differential expression profile in canine mammary gland tumor by next generation sequencing
Hui-Wen Chen et al, 2022, Gene CrossRef - The lncRNA EGFR-AS1 is linked to migration, invasion and apoptosis in glioma cells by targeting miR-133b/RACK1
Zhi-Qiang Dong et al, 2019, Biomedicine & Pharmacotherapy CrossRef - Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
Ingrid Garajová et al, 2017, International Journal of Molecular Sciences CrossRef - High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome
Wuping Li et al, 2017, Cancer Biomarkers CrossRef - miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
Miao Chen et al, 2017, Oncotarget CrossRef - Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
Kenneth K.W. To et al, 2020, Expert Opinion on Drug Discovery CrossRef - MicroRNAs in cancer drug resistance: Basic evidence and clinical applications
Mehri Ghasabi et al, 2019, Journal of Cellular Physiology CrossRef - miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation
Paulína Pidíkova et al, 2020, International Journal of Molecular Sciences CrossRef